MedTrace Logo

Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D

NCT03155477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2017-05-17

No results posted yet for this study

Summary

This a double blind randomised controlled trial (RCT) to determine the effect of Curcuma Xanthorrhiza supplementation on vitamin D3 administration to disease activity (SLEDAI), IL-6 and TGF-β1 serum in SLE patients with hypovitamin D. SLE patients with hypovitamin D had milder disease activity, lower IL-6 and higher TGF-β1 serum level when supplemented with Curcuma Xanthorrhiza and vitamin D3 compared with vitamin D3 and placebo.

Conditions

Interventions

DIETARY_SUPPLEMENT

"Cholecalciferol" and "C. Xanthorrhiza"

Cholecalciferol are given 400 IU 3 times daily for 3 months C. Xanthorrhiza are given 200 mg 3 times daily for 3 months

DIETARY_SUPPLEMENT

"Cholecalciferol" and "placebo"

Cholecalciferol are given 400 IU 3 times daily for 3 months Placebo are given 3 times daily for 3 months

Sponsors & Collaborators

  • Saiful Anwar Hospital

    lead OTHER

Principal Investigators

  • Handono Kalim, Prof.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-10
Primary Completion
2017-03-13
Completion
2017-03-13

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03155477 on ClinicalTrials.gov